We’ve identified five areas that Medicare Advantage plans should consider when shaping their 2025 Part D strategy as the Inflation Reduction Act impacts unfold. The industry is still a few years away from knowing the full impact that the Inflation Reduction Act will have on drug prices. But some critical provisions already impacted drug plan […]
